BlueNalu is a San Diego-based food start up company and it recently raised $60 million from investors in debt financing. The funds are intended to complete the regulatory review with the Food and Drug Administration to kick off testing of cell-based products.
The company has plans to introduce mahi mahi as the first cultured seafood. CEO and President of BlueNalu Lou Cooperhouse states, “This recent financing will allow us to continue advancing our mission and the next phase of our commercialization plans, while we continue to develop strategic partnerships that we expect will provide us with global market reach during the coming years.” By extracting cells from fish and growing the samples in larger bioreactors, the company plans to follow mahi mahi with bluefin tuna.
Image Credit: BlueNalu
What's Driving This Trend
- Lab-grown Seafood
- Opportunities for innovating sustainable, cruelty-free seafood alternatives.
- Cell-based Products
- Potential to revolutionize the meat and dairy industries by creating alternative, ethically sound products.
- Bioreactor Technology
- Innovation opportunities in scaling bioreactor technology for commercial production of cell-based food products.
Who This Affects Most
- Food Industry
- Disruptive innovation potential to challenge the traditional meat, poultry and seafood markets through sustainable, ethical and cruelty-free alternatives.
- Biotechnology Industry
- Innovative technology opportunities to scale up bioreactors for cell-based food production that could disrupt existing supply chains.
- Investment and Finance Industry
- Opportunities for investors to promote socially responsible investments in alternative protein sources.
